Pay in 4 interest-free payments of $25.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques
InChiKey: DWJXYEABWRJFSP-PVCZSOGJSA-N
Molecular Weight: 429
MLKL inhibitor
Dactinomycin - CAS# 50-76-0 Catalog No.:M6979-10 A novel PI3K inhibitor alleviatesDactinomycin, CAS No. 50 76 0, is the most significant member of actinomycines, which are a class of polypeptide antibiotics isolated from soil bacteria of the genus Streptomyces. As one of the older chemotherapy drugs, it has been used for many years. Actinomycin D was the first antibiotic shown to have anti cancer activity. It was first isolated by Selman Waksman and his co worker H. B. Woodruff in 1940. It was approved by the US FDA on December 10,
US$ 39.00
US$ 149.50
US$ 29.00
US$ 129.00
US$ 164.50
US$ 221.81
US$ 188.89
US$ 197.09
US$ 147.83
US$ 103.95
US$ 147.83